How PGT-A Increases IVF Pregnancy Success Rates – 30%

Christmas Decorative Bulbs Scattered with Words Happy HolidaysPreimplantation Genetic Testing for Aneuploidies (PGT-A) will screen the chromosomal normality of each and every embryo culturing in vitro during your upcoming IVF treatment. PGT-A identifies high quality embryos by ruling out those with aneuploidy – an extra or missing chromosome.

PGT-A Increases IVF Pregnancy Chance by up to 30%

Recent research statistics show that a PGT-A biopsy and screening dramatically increases a woman’s chance of conceiving a healthy baby through IVF – by up to 30 percent. Cells are extracted from a blastocyst embryo and evaluated by our expert embryologists. When aneuploidy embryos are detected, they are not transferred. Only high quality embryos are selected for fresh transfer or Frozen Embryo Transfer (FET) procedures.

Poor quality embryos result in:

  • Low chance of pregnancy
  • High chance of miscarriage
  • High risk for birth defect

Candidates for PGT-A in Conjunction with IVF

  • Women over 35 using their own eggs
  • Women having a history of 2 or more miscarriages
  • Women having failed multiple IVF cycles
  • Patients having a family history of genetic disease
  • Couples who have a child born with genetic disease
  • Women who want Family Balancing – Gender Identification & Selection

Cutting-Edge IVF Protocols

PGT-A is conducted in conjunction with Cutting-Edge IVF Protocols.

PGT-A Technology Expertise

Dr. John Zhang’s PGT-A technology expertise in conjunction with IVF offers the highest pregnancy success rates and best overall patient satisfaction. To schedule your initial consultation with Dr. John Zhang call 212.969.7422.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>